Job Trends
The drug, called RGX-314, is a possible one-time treatment for wet AMD, diabetic retinopathy, and other chronic retinal diseases.
Labor Market Reports
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second quarter of 2025, with increased pressure from further layoffs.
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. Learn how strategic insights and targeted outreach can turn awareness into high-converting leads.
Now Hiring
Looking for a job in oncology? Check out the BioSpace list of nine companies hiring life sciences professionals like you.
Looking for a biopharma job in Boston? Check out the BioSpace list of six companies hiring life sciences professionals like you.
Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.
THE LATEST
The capital investment was driven by increasing demand for Lilly’s current medicines, as well as future medicines that will come from its pipeline, the company said.
Invisian Medical awarded Innovative Technology group purchasing contract by Vizient to offer patent-pending Minne Ties fixation technology for jaw fractures and other jaw-related surgeries to its members
With Thanksgiving just around the corner, now is a good time to reflect on things you’re thankful for.
The research will focus on nanotechnology based CBD- products for the treatment of psoriasis and other diseases
We interviewed three women with thriving life sciences careers to dive deeper into what women prioritize in an employer.
AbbVie’s blockbuster drug Humira just got another challenger to its share of the market in the United States when its patent expires in 2023.
It was a busy week for clinical trial announcements. Here’s a look.
FUJIFILM Corporation will invest 13 billion yen (about $120 million) to expand the company’s gene therapy business and establish a new Gene Therapy Innovation Center adjacent to its current facility in College Station, Texas and add about 100 jobs.
MD Anderson researchers find abundant cytokine crowds out helper T cells crucial to treatment
In the world of cancer biology, not all biomarkers are created equal. These molecules that alert doctors that an abnormal process may be underway can appear as an array of aberrant proteins, such as hormones, enzymes or signaling molecules, and vary from patient to patient.